Author information
1 Blake Medical Center Internal Medicine, 2020 59th St W, Bradenton, FL 34209, USA.
2 Southern California Research Center, 131 Orange Avenue, Suite 101, Coronado, CA 92118, USA.
3 St. Mary's Medical Center, 450 Stanyan St, San Francisco, CA 94117, USA.
4 Southern California Liver Centers, 131 Orange Avenue, Suite 101, Coronado, CA 92118, USA. Electronic address: thassanein@livercenters.com.
Abstract
Fatty liver prevalence is increasing and becoming a global health burden. Chronic hepatitis B infection (CHB) is one of the most common chronic viral infections. Steatosis in CHB patients increases risk of cirrhosis and hepatocellular carcinoma. Data from studies on the interaction between CHB and nonalcoholic fatty liver disease are not conclusive. Liver biopsy is the gold standard for diagnosis of fatty liver; however, noninvasive diagnostic tests have been developed to diagnose and predict fibrosis in CHB/NAFLD. Treatment guidelines are not clear.